Graphite Bio
+$0.08 (+3.54%) Today
+$0.01 (+0.43%) As of 8:25 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Graphite Bio and other ETFs, options, and stocks.
About GRPH
Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases.
CEO
Joshua Lehrer-Graiwer
Employees
—
Headquarters
South San Francisco, California
Founded
2017
GRPH Key Statistics
Market cap
135.65M
Price-Earnings ratio
—
Dividend yield
—
Average volume
665.65K
High today
$2.37
Low today
$2.20
Open price
$2.27
Volume
441.65K
52 Week high
$34.00
52 Week low
$2.07
Analyst ratings
67%
of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
GRPH Earnings
-$3.45
-$2.30
-$1.15
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours